INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 65 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2016. The put-call ratio across all filers is 4.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $57,000 | -47.2% | 74,318 | +0.1% | 0.00% | – |
| Q3 2017 | $108,000 | -76.1% | 74,252 | -55.6% | 0.00% | – |
| Q2 2017 | $452,000 | +63.2% | 167,318 | +144.5% | 0.00% | – |
| Q1 2017 | $277,000 | -38.2% | 68,439 | -35.9% | 0.00% | – |
| Q4 2016 | $448,000 | -67.4% | 106,850 | -47.2% | 0.00% | – |
| Q3 2016 | $1,376,000 | -29.5% | 202,293 | -40.1% | 0.00% | -100.0% |
| Q2 2016 | $1,953,000 | -67.1% | 337,897 | -60.3% | 0.00% | -66.7% |
| Q1 2016 | $5,936,000 | +38.6% | 850,408 | +42.9% | 0.00% | +50.0% |
| Q4 2015 | $4,284,000 | +69.1% | 595,053 | +102.4% | 0.00% | +100.0% |
| Q3 2015 | $2,534,000 | +1284.7% | 293,937 | +2501.0% | 0.00% | – |
| Q2 2015 | $183,000 | – | 11,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 435,988 | $1,766,000 | 1.77% |
| WELCH & FORBES LLC | 508,649 | $2,060,000 | 0.06% |
| Hayek Kallen Investment Management | 12,015 | $49,000 | 0.03% |
| Indiana Trust & Investment Management CO | 13,250 | $54,000 | 0.03% |
| FLAGSHIP HARBOR ADVISORS, LLC | 16,007 | $62,000 | 0.02% |
| BOSTON FINANCIAL MANGEMENT LLC | 61,675 | $250,000 | 0.02% |
| HYMAN CHARLES D | 30,000 | $121,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $1,620,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,650 | $367,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 243,781 | $987,000 | 0.00% |